Unconfigured Ad
Collapse
New here? Stop in and introduce yourself. Where you are, what you work on, etc.
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by ECO, 11-21-2011, 08:25 PM
|
16 responses
55,200 views
0 reactions
|
Last Post
by plant_hunt
11-06-2019, 05:43 AM
|
||
|
Started by agout, 10-20-2011, 07:51 PM
|
0 responses
1,274 views
0 reactions
|
Last Post
by agout
10-20-2011, 07:51 PM
|
||
|
Hello
by linux4gen2
Started by linux4gen2, 10-19-2011, 09:19 AM
|
0 responses
997 views
0 reactions
|
Last Post
by linux4gen2
10-19-2011, 09:19 AM
|
||
|
Started by induivain, 10-19-2011, 05:03 AM
|
0 responses
1,056 views
0 reactions
|
Last Post
by induivain
10-19-2011, 05:03 AM
|
||
|
Started by jackiflo, 10-18-2011, 11:05 AM
|
0 responses
1,238 views
0 reactions
|
Last Post
by jackiflo
10-18-2011, 11:05 AM
|
||
|
Started by bjzhong, 10-17-2011, 07:15 PM
|
0 responses
1,022 views
0 reactions
|
Last Post
by bjzhong
10-17-2011, 07:15 PM
|
||
|
hola
by heytreeful
Started by heytreeful, 10-17-2011, 09:50 AM
|
0 responses
1,405 views
0 reactions
|
Last Post
by heytreeful
10-17-2011, 09:50 AM
|
||
|
Started by Nelson Filho, 10-17-2011, 09:35 AM
|
0 responses
1,032 views
0 reactions
|
Last Post
by Nelson Filho
10-17-2011, 09:35 AM
|
||
|
Started by Alex_M, 10-14-2011, 08:23 AM
|
0 responses
1,044 views
0 reactions
|
Last Post
by Alex_M
10-14-2011, 08:23 AM
|
||
|
Started by Orr Shomroni, 10-13-2011, 01:05 PM
|
0 responses
1,166 views
0 reactions
|
Last Post
by Orr Shomroni
10-13-2011, 01:05 PM
|
||
|
Started by hiddenrisk, 10-12-2011, 08:33 PM
|
0 responses
1,111 views
0 reactions
|
Last Post
by hiddenrisk
10-12-2011, 08:33 PM
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...-
Channel: Webinar Series
07-31-2026, 07:00 AM -
Recent Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 08-06-2026, 07:41 AM
|
0 responses
12 views
0 reactions
|
Last Post
by SEQadmin2
08-06-2026, 07:41 AM
|
||
|
Started by SEQadmin2, 08-03-2026, 10:13 AM
|
0 responses
30 views
0 reactions
|
Last Post
by SEQadmin2
08-03-2026, 10:13 AM
|
||
|
Started by SEQadmin2, 07-31-2026, 02:55 AM
|
0 responses
40 views
0 reactions
|
Last Post
by SEQadmin2
07-31-2026, 02:55 AM
|